Loading...
Bristol-Myers Squibb Company
0R1F.L•LSE
HealthcareDrug Manufacturers - General
$72.70
$0.00(0.00%)
Bristol-Myers Squibb Company (0R1F.L) AI-Powered Stock Analysis
See how Bristol-Myers Squibb Company scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerBristol-Myers Squibb Company (0R1F.L) Stock Overall Grade
Bristol-Myers Squibb Company’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B+
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Bristol-Myers Squibb Company's overall stock rating.
Forecast
A+Score
100/100Financial Growth
BScore
65/100Fundamental Growth
C+Score
50/100Key Ratios
C+Score
50/100Sector Comparison
B+Score
75/100Industry Comparison
A+Score
90/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Component Analysis Explained
Understand the key factors behind each Bristol-Myers Squibb Company stock grade, including financials, comparisons, and forecasts.